Who invested in VistaGen Therapeutics?
VistaGen Therapeutics's investors include California Institute For Regenerative Medicine and Montaur Capital Partners.
United States · Venture startup
6 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$45Mraised across 6 rounds since 2007, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $1.9M sold, first sale May 2015
No investor was named in the report.
From a historical funding recordSEC filing: $1.6M sold, first sale Mar 2014
No investor was named in the report.
Reported by sec.govSEC filing: $500K sold, first sale Feb 2012
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
VistaGen Therapeutics's investors include California Institute For Regenerative Medicine and Montaur Capital Partners.
VistaGen Therapeutics has raised $45M across 6 rounds since 2007.
VistaGen Therapeutics's most recent round was a Venture of $1.9M in Aug 2015.
VistaGen Therapeutics's largest round on record is $36M (Undisclosed round), in Apr 2013.
VistaGen Therapeutics's first round on record, in Aug 2007, was backed by Montaur Capital Partners.
VistaGen Therapeutics's latest named round is a Venture, in Aug 2015.
VistaGen Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.